Senior Global Medical DirectorSanofi, Cambridge, MA, USACambridge, Massachusetts, United States
PB0630 - Final Analysis of Long-term Clinical Outcomes of Prophylaxis With a Recombinant Factor VIII Fc Fusion Protein in Adults Aged ≥50 Years With Severe Hemophilia A
Monday, June 26, 202318:30 – 19:30 ET
PB0669 - Final Analysis of Long-term Clinical Outcomes of Recombinant Factor IX Fc Fusion Protein Prophylaxis in Adults ≥50 Years With Severe Hemophilia B
